Sandrine Andrieu - Publications

Affiliations: 
Toulouse 3 

179 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Coley N, Zetterberg H, Cantet C, Guyonnet S, Ashton NJ, Vellas B, Blennow K, Andrieu S. Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial. The Lancet. Healthy Longevity. 5: e120-e130. PMID 38310892 DOI: 10.1016/S2666-7568(23)00255-6  0.356
2023 Delrieu J, Vellas B, Guyonnet S, Cantet C, Ovod V, Li Y, Bollinger J, Bateman R, Andrieu S. Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial. Alzheimer's Research & Therapy. 15: 183. PMID 37872582 DOI: 10.1186/s13195-023-01325-3  0.304
2022 Andre L, Giulioli C, Piau A, Bongard V, Richard E, Moll van Charante EP, Coley N, Andrieu S. Telephone and Smartphone-Based Interventions for Cognitive and Cardio-Metabolic Health in Middle-Aged and Older Adults: A Systematic Review. Clinical Interventions in Aging. 17: 1599-1624. PMID 36393902 DOI: 10.2147/CIA.S352137  0.664
2022 Coley N, Giulioli C, Aisen PS, Vellas B, Andrieu S. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review. Ageing Research Reviews. 82: 101777. PMID 36336171 DOI: 10.1016/j.arr.2022.101777  0.675
2022 Yassine HN, Samieri C, Livingston G, Glass K, Wagner M, Tangney C, Plassman BL, Ikram MA, Voigt RM, Gu Y, O'Bryant S, Minihane AM, Craft S, Fink HA, Judd S, ... Andrieu S, et al. Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group. The Lancet. Healthy Longevity. 3: e501-e512. PMID 35821792 DOI: 10.1016/s2666-7568(22)00120-9  0.32
2022 Belleville S, Cloutier S, Mellah S, Vellas B, Andrieu S, Coley N, Ngandu T. Response to "Upping the dose of dementia risk reduction". Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35575626 DOI: 10.1002/alz.12693  0.595
2022 Belleville S, Cloutier S, Mellah S, Willis S, Vellas B, Andrieu S, Coley N, Ngandu T. Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35049127 DOI: 10.1002/alz.12544  0.635
2021 Coley N, Andre L, Hoevenaar-Blom M, Ngandu T, Beishuizen C, Barbera M, van Wanrooij L, Kivipelto M, Soininen H, van Gool WA, Brayne C, Moll van Charante E, Richard E, Andrieu S. Factors predicting engagement of older adults with a coach-supported eHealth intervention promoting lifestyle change, and associations between engagement and changes in cardiovascular and dementia risk: secondary analysis of an 18-month multinational randomized controlled trial. Journal of Medical Internet Research. PMID 35385395 DOI: 10.2196/32006  0.658
2021 Hafdi M, Eggink E, Hoevenaar-Blom MP, Witvliet MP, Andrieu S, Barnes L, Brayne C, Brooks R, Coley N, Georges J, van der Groep A, van Marwijk H, van der Meijden M, Song L, Song M, et al. Design and Development of a Mobile Health (mHealth) Platform for Dementia Prevention in the Prevention of Dementia by Mobile Phone Applications (PRODEMOS) Project. Frontiers in Neurology. 12: 733878. PMID 34975710 DOI: 10.3389/fneur.2021.733878  0.645
2021 Coley N, Coniasse-Brioude D, Igier V, Fournier T, Poulain JP, Andrieu S. Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial. Alzheimer's Research & Therapy. 13: 157. PMID 34560903 DOI: 10.1186/s13195-021-00904-6  0.667
2021 Mura T, Coley N, Amieva H, Berr C, Gabelle A, Ousset PJ, Vellas B, Andrieu S. Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34482607 DOI: 10.1002/alz.12431  0.687
2021 Eggink E, Hafdi M, Hoevenaar-Blom MP, Song M, Andrieu S, Barnes LE, Birck C, Brooks RL, Coley N, Ford E, Georges J, van der Groep A, van Gool WA, Handels R, Hou H, et al. Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial. Bmj Open. 11: e049762. PMID 34108173 DOI: 10.1136/bmjopen-2021-049762  0.65
2021 Gallini A, Jegou D, Lapeyre-Mestre M, Couret A, Bourrel R, Ousset PJ, Fabre D, Andrieu S, Gardette V. Development and Validation of a Model to Identify Alzheimer's Disease and Related Syndromes in Administrative Data. Current Alzheimer Research. PMID 33882802 DOI: 10.2174/1567205018666210416094639  0.706
2021 González-Bautista E, de Souto Barreto P, Andrieu S, Rolland Y, Vellas B. What day is today? Cognitive capacity and the risk of incident dementia in the context of integrated care for older people (ICOPE Step 1). Aging Clinical and Experimental Research. PMID 33582979 DOI: 10.1007/s40520-021-01803-4  0.327
2020 González-Bautista E, Barreto PDS, Giudici KV, Andrieu S, Rolland Y, Vellas B. Frequency of Conditions Associated with Declines in Intrinsic Capacity According to a Screening Tool in the Context of Integrated Care for Older People The Journal of Frailty & Aging. 10: 94-102. PMID 33575697 DOI: 10.14283/Jfa.2020.42  0.352
2020 Guerville F, De Souto Barreto P, Coley N, Andrieu S, Mangin JF, Chupin M, Payoux P, Ousset PJ, Rolland Y, Vellas B. Kidney Function and Cognitive Decline in Older Adults: Examining the Role of Neurodegeneration. Journal of the American Geriatrics Society. PMID 33217785 DOI: 10.1111/jgs.16954  0.644
2020 Coley N, Hoevenaar-Blom MP, van Dalen JW, Moll van Charante EP, Kivipelto M, Soininen H, Andrieu S, Richard E. Dementia risk scores as surrogate outcomes for lifestyle-based multidomain prevention trials-rationale, preliminary evidence and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32803862 DOI: 10.1002/Alz.12169  0.677
2020 Akenine U, Barbera M, Beishuizen CR, Fallah Pour M, Guillemont J, Rosenberg A, Coley N, Mangialasche F, Salo L, Savy S, Pols AJ, Andrieu S, Richard E, Soininen H, Moll van Charante E, et al. Attitudes of at-risk older adults about prevention of cardiovascular disease and dementia using eHealth: a qualitative study in a European context. Bmj Open. 10: e037050. PMID 32764085 DOI: 10.1136/bmjopen-2020-037050  0.648
2020 Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, Pan A, Zhang C, Jia J, Feng L, Kua EH, Wang YJ, Wang HF, Tan MS, Li JQ, et al. Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32690803 DOI: 10.1136/Jnnp-2019-321913  0.433
2020 Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai H, Baker L, Belleville S, Brodaty H, Brucki SM, Calandri I, Caramelli P, Chen C, Chertkow H, Chew E, et al. World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32627328 DOI: 10.1002/Alz.12123  0.43
2020 van Wanrooij LL, Hoevenaar-Blom MP, Coley N, Ngandu T, Meiller Y, Guillemont J, Rosenberg A, Beishuizen CRL, Moll van Charante EP, Soininen H, Brayne C, Andrieu S, Kivipelto M, Richard E. Pooling individual participant data from randomized controlled trials: Exploring potential loss of information. Plos One. 15: e0232970. PMID 32396543 DOI: 10.1371/journal.pone.0232970  0.584
2020 Gombault-Datzenko E, Gallini A, Carcaillon-Bentata L, Fabre D, Nourhashemi F, Andrieu S, Rachas A, Gardette V. Alzheimer's Disease and Related Syndromes and hospitalization: a nationwide 5-year longitudinal study. European Journal of Neurology. PMID 32285533 DOI: 10.1111/Ene.14256  0.669
2020 Escourrou E, Durrieu F, Chicoulaa B, Dupouy J, Oustric S, Andrieu S, Gardette V. Cognitive, functional, physical, and nutritional status of the oldest old encountered in primary care: a systematic review. Bmc Family Practice. 21: 58. PMID 32220228 DOI: 10.1186/S12875-020-01128-7  0.62
2020 Rosenberg A, Coley N, Soulier A, Kulmala J, Soininen H, Andrieu S, Kivipelto M, Barbera M. Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial. Bmc Geriatrics. 20: 99. PMID 32164544 DOI: 10.1186/S12877-020-1493-4  0.682
2020 Costa N, Mounié M, Pagès A, Guyonnet S, Carrié I, Coley N, Cantet C, Rapp T, Derumeaux-Burel H, Andrieu S, Vellas B, Molinier L. PND44 EVALUATION OF THE EFFICIENCY OF FOUR PREVENTION STRATEGIES IN ALZHEIMER'S DISEASE: RESULTS FROM THE MULTIDOMAIN ALZHEIMER PREVENTIVE TRIAL (MAPT) STUDY Value in Health. 23: S267. DOI: 10.1016/J.Jval.2020.04.937  0.714
2019 Richard E, Moll van Charante EP, Hoevenaar-Blom MP, Coley N, Barbera M, van der Groep A, Meiller Y, Mangialasche F, Beishuizen CB, Jongstra S, van Middelaar T, Van Wanrooij LL, Ngandu T, Guillemont J, Andrieu S, et al. Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial. The Lancet. Digital Health. 1: e424-e434. PMID 33323224 DOI: 10.1016/S2589-7500(19)30153-0  0.633
2019 Delrieu J, Payoux P, Carrié I, Cantet C, Weiner M, Vellas B, Andrieu S. Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31558366 DOI: 10.1016/J.Jalz.2019.07.008  0.404
2019 Giudici KV, de Souto Barreto P, Guerville F, Beard J, Araujo de Carvalho I, Andrieu S, Rolland Y, Vellas B. Associations of C-reactive protein and homocysteine concentrations with the impairment of intrinsic capacity domains over a 5-year follow-up among community-dwelling older adults at risk of cognitive decline (MAPT Study). Experimental Gerontology. 127: 110716. PMID 31493520 DOI: 10.1016/J.Exger.2019.110716  0.341
2019 Coley N, Ngandu T, Lehtisalo J, Soininen H, Vellas B, Richard E, Kivipelto M, Andrieu S. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31047857 DOI: 10.1016/J.Jalz.2019.03.005  0.684
2019 Maltais M, de Souto Barreto P, Pother K, Cantet C, Andrieu S, Rolland Y, Vellas B. Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial. Experimental Gerontology. PMID 30817982 DOI: 10.1016/J.Exger.2019.02.010  0.324
2018 Coley N, Rosenberg A, van Middelaar T, Soulier A, Barbera M, Guillemont J, Steensma J, Igier V, Eskelinen M, Soininen H, Moll van Charante E, Richard E, Kivipelto M, Andrieu S, et al. Older Adults' Reasons for Participating in an eHealth Prevention Trial: A Cross-Country, Mixed-Methods Comparison. Journal of the American Medical Directors Association. PMID 30541689 DOI: 10.1016/J.Jamda.2018.10.019  0.643
2018 Coley N, Raman R, Donohue MC, Aisen PS, Vellas B, Andrieu S. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline? The Journal of Nutrition, Health & Aging. 22: 982-998. PMID 30272103 DOI: 10.1007/S12603-018-1052-2  0.655
2018 Tabue-Teguo M, Souza PBd, Cantet C, Andrieu S, Simo N, Fougère B, Dartigues JF, Vellas B. Effect of Multidomain Intervention, Omega-3 Polyunsaturated Fatty Acids Supplementation or their Combinaison on Cognitive Function in Non-Demented Older Adults According to Frail Status: Results from the MAPT Study. Journal of Nutrition Health & Aging. 22: 923-927. PMID 30272094 DOI: 10.1007/S12603-018-1024-6  0.346
2018 Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V. Anticholinergic exposure and cognitive decline in older adults: Effect of anticholinergic exposure definitions in a 3-year analysis of the Multidomain Alzheimer Preventive Trial (MAPT) study. British Journal of Clinical Pharmacology. PMID 30098049 DOI: 10.1111/Bcp.13734  0.771
2018 Chhetri JK, de Souto Barreto P, Cantet C, Pothier K, Cesari M, Andrieu S, Coley N, Vellas B. Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Function in Older Subjects with Increased CAIDE Dementia Scores. Journal of Alzheimer's Disease : Jad. PMID 29865075 DOI: 10.3233/Jad-180209  0.674
2018 Rapp T, Andrieu S, Chartier F, Deberdt W, Reed C, Belger M, Vellas B. Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 295-303. PMID 29566836 DOI: 10.1016/J.Jval.2017.09.019  0.388
2018 Barbera M, Mangialasche F, Jongstra S, Guillemont J, Ngandu T, Beishuizen C, Coley N, Brayne C, Andrieu S, Richard E, Soininen H, Kivipelto M. Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial. Journal of Alzheimer's Disease : Jad. 62: 649-663. PMID 29480185 DOI: 10.3233/Jad-170858  0.695
2018 Wargny M, Gallini A, Hanaire H, Nourhashemi F, Andrieu S, Gardette V. Diabetes Care and Dementia Among Older Adults: A Nationwide 3-Year Longitudinal Study. Journal of the American Medical Directors Association. PMID 29396187 DOI: 10.1016/J.Jamda.2017.12.006  0.653
2018 Li J, Cesari M, Del Campo N, Andrieu S, Dong B, Lim WS, Vellas B. Impact of diabetes on caregiver stress in patients with Alzheimer's disease: data from the ICTUS study. International Psychogeriatrics. 1-9. PMID 29380719 DOI: 10.1017/S1041610217002460  0.368
2018 de Mauléon A, Soto M, Kiyasova V, Delrieu J, Guignot I, Galtier S, Lilamand M, Cantet C, Lala F, Sastre N, Andrieu S, Pueyo M, Ousset PJ, Vellas B. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results. The Journal of Prevention of Alzheimer's Disease. 4: 183-193. PMID 29182709 DOI: 10.14283/jpad.2017.8  0.321
2018 Hooper C, De Souto Barreto P, Coley N, Cantet C, Cesari M, Andrieu S, Vellas B. Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index. The Journal of Nutrition, Health & Aging. 21: 988-993. PMID 29083439 DOI: 10.1007/S12603-017-0957-5  0.632
2017 Hooper C, De Souto Barreto P, Coley N, Caussé E, Payoux P, Salabert AS, Cesari M, Andrieu S, Bowman GL, Weiner M, Vellas B. Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia. The Journal of Nutrition, Health & Aging. 21: 1075-1080. PMID 29188863 DOI: 10.1007/S12603-017-0989-X  0.662
2017 Hooper C, De Souto Barreto P, Coley N, Cesari M, Payoux P, Salabert AS, Andrieu S, Vellas B. Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia. Frontiers in Medicine. 4: 173. PMID 29164115 DOI: 10.3389/Fmed.2017.00173  0.65
2017 Barreto PS, Rolland Y, Cesari M, Dupuy C, Andrieu S, Vellas B. Effects of multidomain lifestyle intervention, omega-3 supplementation or their combination on physical activity levels in older adults: secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT) randomised controlled trial. Age and Ageing. 1-8. PMID 29136094 DOI: 10.1093/Ageing/Afx164  0.372
2017 Hoevenaar-Blom MP, Guillemont J, Ngandu T, Beishuizen CRL, Coley N, Moll van Charante EP, Andrieu S, Kivipelto M, Soininen H, Brayne C, Meiller Y, Richard E. Improving data sharing in research with context-free encoded missing data. Plos One. 12: e0182362. PMID 28898245 DOI: 10.1371/Journal.Pone.0182362  0.624
2017 Coley N, Andrieu S. Lessons from the Multidomain Alzheimer Preventive Trial - Authors' reply. The Lancet. Neurology. 16: 586. PMID 28721923 DOI: 10.1016/S1474-4422(17)30226-0  0.689
2017 Moon SY, de Souto Barreto P, Chupin M, Mangin JF, Bouyahia A, Fillon L, Andrieu S, Vellas B. Associations between white matter hyperintensities and cognitive decline over three years in non-dementia older adults with memory complaints. Journal of the Neurological Sciences. 379: 266-270. PMID 28716257 DOI: 10.1016/J.Jns.2017.06.031  0.347
2017 Minois N, Lauwers-Cances V, Savy S, Attal M, Andrieu S, Anisimov V, Savy N. Using Poisson-gamma model to evaluate the duration of recruitment process when historical trials are available. Statistics in Medicine. PMID 28608361 DOI: 10.1002/Sim.7365  0.337
2017 Escourrou E, Cesari M, Chicoulaa B, Fougère B, Vellas B, Andrieu S, Oustric S. How Older Persons Perceive the Loss of Independence: The Need of a Holistic Approach to Frailty The Journal of Frailty & Aging. 6: 107-112. PMID 28555713 DOI: 10.14283/Jfa.2017.3  0.305
2017 Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. The Lancet. Neurology. PMID 28359749 DOI: 10.1016/S1474-4422(17)30040-6  0.67
2017 Beishuizen CR, Coley N, Moll van Charante EP, van Gool WA, Richard E, Andrieu S. Determinants of Dropout and Nonadherence in a Dementia Prevention Randomized Controlled Trial: The Prevention of Dementia by Intensive Vascular Care Trial. Journal of the American Geriatrics Society. PMID 28263374 DOI: 10.1111/jgs.14834  0.66
2017 Gallini A, Coley N, Andrieu S, Lapeyre-Mestre M, Gardette V. Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007-2012. Fundamental & Clinical Pharmacology. PMID 28258589 DOI: 10.1111/Fcp.12281  0.781
2017 Qualls C, Waters DL, Vellas B, Villareal DT, Garry PJ, Gallini A, Andrieu S. Reversible States of Physical and/or Cognitive Dysfunction: A 9-Year Longitudinal Study. The Journal of Nutrition, Health & Aging. 21: 271-275. PMID 28244566 DOI: 10.1007/S12603-017-0878-3  0.305
2017 Landi F, Cesari M, Calvani R, Cherubini A, Di Bari M, Bejuit R, Mshid J, Andrieu S, Sinclair AJ, Sieber CC, Vellas B, Topinkova E, Strandberg T, Rodriguez-Manas L, Lattanzio F, et al. The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods. Aging Clinical and Experimental Research. PMID 28144914 DOI: 10.1007/S40520-016-0715-2  0.384
2017 Coley N, Ngandu T, Cantet C, Lehtisalo J, Vellas B, Kivipelto M, Andrieu S. ADHERENCE TO MULTIDOMAIN INTERVENTIONS FOR THE PREVENTION OF ALZHEIMER’S DISEASE: DATA FROM THE MAPT AND FINGER TRIALS Alzheimer's & Dementia. 13: P895-P896. DOI: 10.1016/J.Jalz.2017.07.306  0.676
2016 Aisen P, Touchon J, Andrieu S, Boada M, Doody R, Nosheny RL, Langbaum JB, Schneider L, Hendrix S, Wilcock G, Molinuevo JL, Ritchie C, Ousset PJ, Cummings J, Sperling R, et al. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. The Journal of Prevention of Alzheimer's Disease. 3: 68-74. PMID 29210442 DOI: 10.14283/jpad.2016.97  0.319
2016 Campo ND, Cesari M, Canevelli M, Hoogendijk EO, Lilamand M, Kelaiditi E, Soto ME, Ousset PJ, Weiner MW, Andrieu S, Vellas B. Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians. Journal of the American Medical Directors Association. 17: 913-20. PMID 27670604 DOI: 10.1016/J.Jamda.2016.06.005  0.352
2016 Jongstra S, Beishuizen C, Andrieu S, Barbera M, van Dorp M, van de Groep B, Guillemont J, Mangialasche F, van Middelaar T, Moll van Charante E, Soininen H, Kivipelto M, Richard E. Development and Validation of an Interactive Internet Platform for Older People: The Healthy Ageing Through Internet Counselling in the Elderly Study. Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association. PMID 27463120 DOI: 10.1089/Tmj.2016.0066  0.31
2016 Coley N, Gallini A, Ousset PJ, Vellas B, Andrieu S. Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27423962 DOI: 10.1016/J.Jalz.2016.06.002  0.711
2016 Kelaiditi E, Canevelli M, Andrieu S, Del Campo N, Soto ME, Vellas B, Cesari M. Frailty Index and Cognitive Decline in Alzheimer's Disease: Data from the Impact of Cholinergic Treatment USe Study. Journal of the American Geriatrics Society. 64: 1165-70. PMID 27321595 DOI: 10.1111/jgs.13956  0.328
2016 Richard E, Jongstra S, Soininen H, Brayne C, Moll van Charante EP, Meiller Y, van der Groep B, Beishuizen CR, Mangialasche F, Barbera M, Ngandu T, Coley N, Guillemont J, Savy S, Dijkgraaf MG, ... ... Andrieu S, et al. Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment. Bmj Open. 6: e010806. PMID 27288376 DOI: 10.1136/bmjopen-2015-010806  0.647
2016 Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, et al. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 12: 292-323. PMID 27012484 DOI: 10.1016/J.Jalz.2016.02.002  0.391
2016 Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet. Neurology. 15: 455-532. PMID 26987701 DOI: 10.1016/S1474-4422(16)00062-4  0.424
2016 Fougère B, Aubertin-Leheudre M, Vellas B, Andrieu S, Demougeot L, Cluzan C, Cesari M. Clinical research for older adults in rural areas: the MINDED study experience. Age (Dordrecht, Netherlands). 38: 30. PMID 26891623 DOI: 10.1007/S11357-016-9892-3  0.347
2016 Amieva H, Robert PH, Grandoulier AS, Meillon C, De Rotrou J, Andrieu S, Berr C, Desgranges B, Dubois B, Girtanner C, Joël ME, Lavallart B, Nourhashemi F, Pasquier F, Rainfray M, et al. Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial. International Psychogeriatrics / Ipa. 28: 707-17. PMID 26572551 DOI: 10.1017/S1041610215001830  0.461
2016 Kelaiditi E, Andrieu S, Cantet C, Vellas B, Cesari M. Frailty Index and Incident Mortality, Hospitalization, and Institutionalization in Alzheimer's Disease: Data From the ICTUS Study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 71: 543-8. PMID 26273022 DOI: 10.1093/Gerona/Glv137  0.387
2016 Richard E, Mangialsche F, Andrieu S, Barbera M, Beishuizen C, Brayne C, Coley N, van Gool WA, Guillemont J, Jongstra S, Moll van Charante EP, Ngandu T, Soininen H, Kivipelto M. P4-392: Healthy Ageing Through Internet Counselling in the Elderly (HATICE): an Ongoing Randomised Controlled Trial Alzheimer's & Dementia. 12: P1187-P1188. DOI: 10.1016/J.Jalz.2016.07.137  0.604
2015 Andrieu S, Coley N, Rolland Y, Cantet C, Arnaud C, Guyonnet S, Nourhashemi F, Grand A, Vellas B. Assessing Alzheimer's disease patients' quality of life: Discrepancies between patient and caregiver perspectives. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26602086 DOI: 10.1016/J.Jalz.2015.09.003  0.656
2015 Coley N, Gallini A, Garès V, Gardette V, Andrieu S. A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort. Journal of the American Medical Directors Association. 16: 1104.e1-7. PMID 26593306 DOI: 10.1016/J.Jamda.2015.09.010  0.772
2015 Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S. Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial. Journal of Alzheimer's Disease : Jad. 48: 793-804. PMID 26402073 DOI: 10.3233/Jad-150013  0.691
2015 Andrieu S, Coley N, Lovestone S, Aisen PS, Vellas B. Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions. The Lancet. Neurology. 14: 926-44. PMID 26213339 DOI: 10.1016/S1474-4422(15)00153-2  0.7
2015 de Souto Barreto P, Andrieu S, Payoux P, Demougeot L, Rolland Y, Vellas B. Physical Activity and Amyloid-β Brain Levels in Elderly Adults with Intact Cognition and Mild Cognitive Impairment. Journal of the American Geriatrics Society. 63: 1634-9. PMID 26200930 DOI: 10.1111/Jgs.13530  0.332
2015 Coley N, Vaurs C, Andrieu S. Nutrition and Cognition in Aging Adults. Clinics in Geriatric Medicine. 31: 453-64. PMID 26195103 DOI: 10.1016/J.Cger.2015.04.008  0.682
2015 Coley N, Gallini A, Andrieu S. Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics. Cns Drugs. 29: 519-28. PMID 26188654 DOI: 10.1007/s40263-015-0256-9  0.685
2015 Gallini A, Gardette V, Lapeyre-Mestre M, De Souto Barreto P, Vellas B, Andrieu S, Rolland Y. Dementia diagnosis and influenza vaccination in French nursing home residents Journal of the American Geriatrics Society. 63: 1256-1258. PMID 26096405 DOI: 10.1111/Jgs.13515  0.655
2015 Payoux P, Delrieu J, Gallini A, Adel D, Salabert AS, Hitzel A, Cantet C, Tafani M, De Verbizier D, Darcourt J, Fernandez P, Monteil J, Carrié I, Voisin T, Gillette-Guyonnet S, ... ... Andrieu S, et al. Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1459-68. PMID 25952279 DOI: 10.1007/S00259-015-3067-9  0.331
2015 Soto M, Andrieu S, Gares V, Cesari M, Gillette-Guyonnet S, Cantet C, Vellas B, Nourhashémi F. Living Alone with Alzheimer's Disease and the Risk of Adverse Outcomes: Results from the Plan de Soin et d'Aide dans la maladie d'Alzheimer Study. Journal of the American Geriatrics Society. 63: 651-8. PMID 25900483 DOI: 10.1111/Jgs.13347  0.406
2015 Gallini A, Gardette V, Oumouhou N, Andrieu S, Donohue JM. Evolution of general practitioners' preferences for antipsychotics in France, 2003-2010. Psychiatric Services (Washington, D.C.). 66: 434-7. PMID 25588416 DOI: 10.1176/Appi.Ps.201400020  0.57
2015 Garès V, Andrieu S, Dupuy JF, Savy N. An omnibus test for several hazard alternatives in prevention randomized controlled clinical trials. Statistics in Medicine. 34: 541-57. PMID 25388274 DOI: 10.1002/Sim.6366  0.311
2015 Di Stefano F, Epelbaum S, Coley N, Cantet C, Ousset PJ, Hampel H, Bakardjian H, Lista S, Vellas B, Dubois B, Andrieu S, Baglio F. Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial Journal of Alzheimer's Disease. 48: 793-804. DOI: 10.3233/JAD-150013  0.694
2015 Coley N, Garès V, Vellas B, Burns A, Pasquier F, Frisoni G, Salmon E, Michel JP, Boada M, Dartigues JF, Olde-Rikkert MGM, Rigaud AS, Winblad B, Malick A, Frölich L, ... ... Andrieu S, et al. A Longitudinal Study of Transitions Between Informal and Formal Care in Alzheimer Disease Using Multistate Models in the European ICTUS Cohort Journal of the American Medical Directors Association. 16: 1104.e1-1104.e7. DOI: 10.1016/j.jamda.2015.09.010  0.752
2015 Vellas B, Carrie I, Guyonnet S, Touchon J, Dantoine T, Dartigues J, Cufi MN, Bordes S, Gasnier Y, Robert P, Bories L, Rouaud O, Desclaux F, Sudres K, Bonnefoy M, ... ... Andrieu S, et al. DT-01-01: MAPT (multi-domain Alzheimer's prevention trial): Results at 36 months Alzheimer's & Dementia. 11: P331-P331. DOI: 10.1016/J.Jalz.2015.08.151  0.638
2014 Vellas B, Sampaio C, Bateman R, Boxer A, Carrillo MC, Cummings J, Dubois B, Hampel H, Katz R, Khachaturian Z, Gauthier S, Johnson K, Karlawish J, Mintun M, Petersen R, ... ... Andrieu S, et al. EU./U.S. CTAD Task Force on Alzheimer's Trial Populations. The Journal of Prevention of Alzheimer's Disease. 1: 110-116. PMID 29255837 DOI: 10.14283/jpad.2014.6  0.374
2014 Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, Herholz K, Jack CR, Sperling R, Cummings J, Blennow K, O'Bryant S, Frisoni GB, Khachaturian A, Kivipelto M, Klunk W, ... ... Andrieu S, et al. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. The Journal of Prevention of Alzheimer's Disease. 1: 181-202. PMID 26478889 DOI: 10.14283/jpad.2014.32  0.314
2014 Dacks PA, Andrieu S, Blacker D, Carman AJ, Green AM, Grodstein F, Henderson VW, James BD, Lane RF, Lau J, Lin PJ, Reeves BC, Shah RC, Vellas B, Yaffe K, et al. Dementia Prevention: optimizing the use of observational data for personal, clinical, and public health decision-making. The Journal of Prevention of Alzheimer's Disease. 1: 117-123. PMID 26146610  0.324
2014 Soto M, Andrieu S, Nourhashemi F, Ousset PJ, Ballard C, Robert P, Vellas B, Lyketsos CG, Rosenberg PB. Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design. International Psychogeriatrics / Ipa. 1-17. PMID 25226218 DOI: 10.1017/S1041610214001720  0.417
2014 Tavassoli N, Guyonnet S, Abellan Van Kan G, Sourdet S, Krams T, Soto ME, Subra J, Chicoulaa B, Ghisolfi A, Balardy L, Cestac P, Rolland Y, Andrieu S, Nourhashemi F, Oustric S, et al. Description of 1,108 older patients referred by their physician to the "Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of Disability" at the gerontopole. The Journal of Nutrition, Health & Aging. 18: 457-64. PMID 24886728 DOI: 10.1007/S12603-014-0462-Z  0.315
2014 Cesari M, Demougeot L, Boccalon H, Guyonnet S, Vellas B, Andrieu S. The Multidomain Intervention to preveNt disability in ElDers (MINDED) project: rationale and study design of a pilot study. Contemporary Clinical Trials. 38: 145-54. PMID 24768939 DOI: 10.1016/J.Cct.2014.04.006  0.363
2014 Robert PH, König A, Amieva H, Andrieu S, Bremond F, Bullock R, Ceccaldi M, Dubois B, Gauthier S, Kenigsberg PA, Nave S, Orgogozo JM, Piano J, Benoit M, Touchon J, et al. Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty. Frontiers in Aging Neuroscience. 6: 54. PMID 24715864 DOI: 10.3389/Fnagi.2014.00054  0.387
2014 Kahle-Wrobleski K, Coley N, Lepage B, Cantet C, Vellas B, Andrieu S. Understanding the complexities of functional ability in Alzheimer's disease: more than just basic and instrumental factors. Current Alzheimer Research. 11: 357-66. PMID 24635843 DOI: 10.2174/1567205011666140317101419  0.677
2014 Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M. Advances in the prevention of Alzheimer's disease and dementia. Journal of Internal Medicine. 275: 229-50. PMID 24605807 DOI: 10.1111/Joim.12178  0.507
2014 Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S. A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study. Cns Drugs. 28: 157-70. PMID 24408842 DOI: 10.1007/S40263-013-0133-3  0.695
2014 Gallini A, Andrieu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette V. Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 95-104. PMID 24126116 DOI: 10.1016/J.Euroneuro.2013.09.003  0.705
2014 Gallini A, Gardette V, Lapeyre-Mestreb M, Andrieu S. Effet de la démence sur le recours à la vaccination contre la grippe saisonnière chez les personnes âgées : une analyse dans l’échantillon généralisé de bénéficiaires Revue D'éPidéMiologie Et De Santé Publique. 62: S122-S123. DOI: 10.1016/J.Respe.2014.05.023  0.607
2014 Gallini A, Gardette V, Lapeyre-Mestre M, Andrieu S. Recours à la vaccination contre la grippe saisonnière chez les personnes âgées : effet de la démence Revue D'éPidéMiologie Et De Santé Publique. 62: S82-S83. DOI: 10.1016/J.Respe.2014.01.037  0.663
2014 Di Stefano F, Epelbaum S, Coley N, Cantet C, Bakardjian H, Lista S, Hampel H, Vellas B, Dubois B, Andrieu S. P3-245: FREE AND CUED SELECTIVE REMINDING TEST (FCSRT) PERFORMANCE IN THE PREDICTION OF ALZHEIMER'S DISEASE DEMENTIA: DATA FROM A LARGE PREVENTION TRIAL (GUIDAGE) Alzheimer's & Dementia. 10: P721-P721. DOI: 10.1016/j.jalz.2014.05.1336  0.659
2013 Cesari M, Andrieu S, Rolland Y, Nourhashemi F, Vellas B. The cognitive impairment of frail older persons. The Journal of Nutrition, Health & Aging. 17: 735-7. PMID 24154643 DOI: 10.1007/S12603-013-0396-X  0.327
2013 Kelaiditi E, Cesari M, Canevelli M, van Kan GA, Ousset PJ, Gillette-Guyonnet S, Ritz P, Duveau F, Soto ME, Provencher V, Nourhashemi F, Salvà A, Robert P, Andrieu S, Rolland Y, et al. Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. The Journal of Nutrition, Health & Aging. 17: 726-34. PMID 24154642 DOI: 10.1007/S12603-013-0367-2  0.398
2013 Robert PH, Konig A, Andrieu S, Bremond F, Chemin I, Chung PC, Dartigues JF, Dubois B, Feutren G, Guillemaud R, Kenisberg PA, Nave S, Vellas B, Verhey F, Yesavage J, et al. Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. The Journal of Nutrition, Health & Aging. 17: 653-60. PMID 24097018 DOI: 10.1007/S12603-013-0046-3  0.44
2013 Ferry M, Coley N, Andrieu S, Bonhomme C, Caubère JP, Cesari M, Gautry J, Garcia Sanchez I, Hugonot L, Mansuy L, Pahor M, Pariente J, Ritz P, Salva A, Sijben J, et al. How to design nutritional intervention trials to slow cognitive decline in apparently healthy populations and apply for efficacy claims: a statement from the International Academy on Nutrition and Aging Task Force. The Journal of Nutrition, Health & Aging. 17: 619-23. PMID 23933873 DOI: 10.1007/S12603-013-0350-Y  0.674
2013 Vellas B, Carrillo MC, Sampaio C, Brashear HR, Siemers E, Hampel H, Schneider LS, Weiner M, Doody R, Khachaturian Z, Cedarbaum J, Grundman M, Broich K, Giacobini E, Dubois B, ... ... Andrieu S, et al. Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 438-44. PMID 23809364 DOI: 10.1016/J.Jalz.2013.03.007  0.429
2013 Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! European Journal of Clinical Pharmacology. 69: 1589-97. PMID 23588564 DOI: 10.1007/S00228-013-1506-8  0.743
2013 Gallini A, Gardette V, Vellas B, Lapeyre-Mestre M, Andrieu S, Brefel-Courbon C. Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease. Drugs & Aging. 30: 439-45. PMID 23512718 DOI: 10.1007/S40266-013-0070-3  0.731
2013 Canevelli M, Adali N, Cantet C, Andrieu S, Bruno G, Cesari M, Vellas B. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. Journal of Neurology. 260: 1859-65. PMID 23504051 DOI: 10.1007/S00415-013-6893-3  0.428
2013 Cedarbaum JM, Jaros M, Hernandez C, Coley N, Andrieu S, Grundman M, Vellas B. Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S45-55. PMID 22658286 DOI: 10.1016/J.Jalz.2011.11.002  0.706
2013 Mangialasche F, Kivipelto M, Andrieu S, Coley N, Ngandu T, Moll van Charante E, Brayne C, Meiller Y, Van de Groep B, Soininen H, van Willem Gool A, Richard E. P4-398: Use of new technology to improve dementia prevention: The Healthy Aging Through Internet Counseling in the Elderly (HATICE) project Alzheimer's & Dementia. 9: P881-P881. DOI: 10.1016/j.jalz.2013.08.231  0.602
2012 Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet. Neurology. 11: 851-9. PMID 22959217 DOI: 10.1016/S1474-4422(12)70206-5  0.671
2012 Gardette V, Lapeyre-Mestre M, Coley N, Cantet C, Montastruc JL, Vellas B, Andrieu S. Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity. Current Alzheimer Research. 9: 1106-16. PMID 22950915 DOI: 10.2174/156720512803569037  0.791
2012 Richard E, Andrieu S, Solomon A, Mangialasche F, Ahtiluoto S, Moll van Charante EP, Coley N, Fratiglioni L, Neely AS, Vellas B, van Gool WA, Kivipelto M. Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI). Journal of the Neurological Sciences. 322: 64-70. PMID 22818266 DOI: 10.1016/j.jns.2012.06.012  0.679
2012 Vellas B, Hausner L, Frölich L, Cantet C, Gardette V, Reynish E, Gillette S, Agüera-Morales E, Auriacombe S, Boada M, Bullock R, Byrne J, Camus V, Cherubini A, Eriksdotter-Jönhagen M, ... ... Andrieu S, et al. Progression of Alzheimer disease in Europe: data from the European ICTUS study. Current Alzheimer Research. 9: 902-12. PMID 22742853 DOI: 10.2174/156720512803251066  0.697
2012 Carrié I, van Kan GA, Gillette-Guyonnet S, Andrieu S, Dartigues JF, Touchon J, Dantoine T, Rouaud O, Bonnefoy M, Robert P, Cuffi MN, Bories L, Bordes S, Gasnier Y, Desclaux F, et al. Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial). The Journal of Nutrition, Health & Aging. 16: 355-9. PMID 22499458 DOI: 10.1007/S12603-012-0046-8  0.349
2012 Andrieu S, Coley N, Gardette V, Subra J, Oustric S, Fournier T, Poulain JP, Coniasse-Brioude D, Igier V, Vellas B, Grand A. Representations and practices of prevention in elderly populations: investigating acceptance to participate in and adhesion to an intervention study for the prevention of Alzheimer's disease (ACCEPT study)--the need for a multidisciplinary approach. The Journal of Nutrition, Health & Aging. 16: 352-4. PMID 22499457 DOI: 10.1007/S12603-012-0045-9  0.783
2012 Salvà A, Roqué M, Rojano X, Inzitari M, Andrieu S, Schiffrin EJ, Guigoz Y, Vellas B. Falls and risk factors for falls in community-dwelling adults with dementia (NutriAlz trial). Alzheimer Disease and Associated Disorders. 26: 74-80. PMID 22354139 DOI: 10.1097/WAD.0b013e318215ca90  0.308
2012 Soto ME, Andrieu S, Villars H, Secher M, Gardette V, Coley N, Nourhashemi F, Vellas B. Improving care of older adults with dementia: description of 6299 hospitalizations over 11 years in a special acute care unit. Journal of the American Medical Directors Association. 13: 486.e1-6. PMID 22264688 DOI: 10.1016/J.Jamda.2011.12.058  0.762
2012 Soto ME, Secher M, Gillette-Guyonnet S, Abellan van Kan G, Andrieu S, Nourhashemi F, Rolland Y, Vellas B. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 647-54. PMID 22045479 DOI: 10.3233/Jad-2011-110713  0.401
2012 Abellan van Kan G, Rolland Y, Gillette-Guyonnet S, Gardette V, Annweiler C, Beauchet O, Andrieu S, Vellas B. Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 425-32. PMID 21975092 DOI: 10.1093/Gerona/Glr177  0.627
2012 Sanz CM, Hanaire H, Vellas BJ, Sinclair AJ, Andrieu S. Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort. Diabetic Medicine : a Journal of the British Diabetic Association. 29: 541-8. PMID 21913970 DOI: 10.1111/J.1464-5491.2011.03445.X  0.337
2011 Salvà A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, Rojano-i-Luque X, Guigoz Y, Vellas B. Health and nutrition promotion program for patients with dementia (NutriAlz): cluster randomized trial. The Journal of Nutrition, Health & Aging. 15: 822-30. PMID 22159768 DOI: 10.1007/S12603-011-0363-3  0.363
2011 Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B. Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 579-92. PMID 22055975 DOI: 10.1016/J.Jalz.2011.02.009  0.794
2011 Arbus C, Gardette V, Cantet CE, Andrieu S, Nourhashémi F, Schmitt L, Vellas B. Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study. The Journal of Nutrition, Health & Aging. 15: 609-17. PMID 21968854 DOI: 10.1007/S12603-011-0061-1  0.664
2011 Vellas B, Aisen PS, Sampaio C, Carrillo M, Scheltens P, Scherrer B, Frisoni GB, Weiner M, Schneider L, Gauthier S, Gispen-de Wied CC, Hendrix S, Feldman H, Cedarbaum J, Petersen R, ... ... Andrieu S, et al. Prevention trials in Alzheimer's disease: an EU-US task force report. Progress in Neurobiology. 95: 594-600. PMID 21925234 DOI: 10.1016/J.Pneurobio.2011.08.014  0.354
2011 Andrieu S, Aboderin I, Baeyens JP, Beard J, Benetos A, Berrut G, Brainin M, Cha HB, Chen LK, Du P, Forette B, Forette F, Franco A, Fratiglioni L, Gillette-Guyonnet S, et al. IAGG workshop: health promotion program on prevention of late onset dementia. The Journal of Nutrition, Health & Aging. 15: 562-75. PMID 21808935 DOI: 10.1007/S12603-011-0142-1  0.413
2011 Vellas B, Pesce A, Robert PH, Aisen PS, Ancoli-Israel S, Andrieu S, Cedarbaum J, Dubois B, Siemers E, Spire JP, Weiner MW, May TS. AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e109-17. PMID 21784343 DOI: 10.1016/J.Jalz.2010.05.2020  0.417
2011 Coley N, Andrieu S, Jaros M, Weiner M, Cedarbaum J, Vellas B. Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 602-610.e2. PMID 21745761 DOI: 10.1016/J.Jalz.2011.01.005  0.716
2011 Rapp T, Grand A, Cantet C, Andrieu S, Coley N, Portet F, Vellas B. Public financial support receipt and non-medical resource utilization in Alzheimer's disease results from the PLASA study. Social Science & Medicine (1982). 72: 1310-6. PMID 21463914 DOI: 10.1016/J.Socscimed.2011.02.039  0.642
2011 Coley N, Gardette V, Cantet C, Gillette-Guyonnet S, Nourhashemi F, Vellas B, Andrieu S. How should we deal with missing data in clinical trials involving Alzheimer's disease patients? Current Alzheimer Research. 8: 421-33. PMID 21244348 DOI: 10.2174/156720511795745339  0.798
2011 Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khachaturian ZS, Dubois B, Feldman HH, Petersen RC, Siemers E, Doody RS, Hendrix SB, Grundman M, Schneider LS, Schindler RJ, Salmon E, et al. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 76: 280-6. PMID 21178097 DOI: 10.1212/Wnl.0B013E318207B1B9  0.316
2011 Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, et al. Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology. 95: 579-93. PMID 21130138 DOI: 10.1016/J.Pneurobio.2010.11.005  0.682
2011 Coley N, Gardette V, Cantet C, Gillette-Guyonnet S, Nourhashemi F, Vellas B, Andrieu S. How Should We Deal with Missing Data in Clinical Trials Involving Alzheimer's Disease Patients? Current Alzheimer Research. 999: 1-12. DOI: 10.2174/1567211212443482050  0.78
2010 Gustavsson A, Jonsson L, Rapp T, Reynish E, Ousset PJ, Andrieu S, Cantet C, Winblad B, Vellas B, Wimo A. Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study. The Journal of Nutrition, Health & Aging. 14: 648-54. PMID 20922341 DOI: 10.1007/S12603-010-0311-7  0.345
2010 Wortmann M, Andrieu S, Mackell J, Knox S. Eolving attitudes to Alzheimer’s disease among the general public and caregivers in Europe: Findings from the IMPACT survey Journal of Nutrition Health & Aging. 14: 531-536. PMID 20818467 DOI: 10.1007/S12603-010-0264-X  0.383
2010 Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Giraudeau B, Cantet C, Coley N, Vellas B. Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study). Bmj (Clinical Research Ed.). 340: c2466. PMID 20522656 DOI: 10.1136/Bmj.C2466  0.647
2010 Hausner L, Frölich L, Gardette V, Reynish E, Ousset PJ, Andrieu S, Vellas B, On Behalf Of The Ictus-Eadc Study Group. Regional variation on the presentation of Alzheimer's disease patients in memory clinics within Europe: data from the ICTUS study. Journal of Alzheimer's Disease : Jad. 21: 155-65. PMID 20413884 DOI: 10.3233/Jad-2010-091489  0.678
2010 Gardette V, Andrieu S, Lapeyre-Mestre M, Coley N, Cantet C, Ousset PJ, Grand A, Monstastruc JL, Vellas B. Predictive factors of discontinuation and switch of cholinesterase inhibitors in community-dwelling patients with Alzheimer's disease: a 2-year prospective, multicentre, cohort study. Cns Drugs. 24: 431-42. PMID 20369907 DOI: 10.2165/11318010-000000000-00000  0.789
2010 Voisin T, Andrieu S, Cantet C, Vellas B. Predictive factors of hospitalizations in Alzheimer's disease: a two-year prospective study in 686 patients of the REAL.FR study. The Journal of Nutrition, Health & Aging. 14: 288-91. PMID 20305996 DOI: 10.1007/S12603-010-0063-4  0.306
2010 Arbus C, Gardette V, Bui E, Cantet C, Andrieu S, Nourhashémi F, Schmitt L, Vellas B. Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort. International Psychogeriatrics / Ipa. 22: 120-8. PMID 19735591 DOI: 10.1017/S1041610209990780  0.686
2009 Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. The Journal of Nutrition, Health & Aging. 13: 881-9. PMID 19924348 DOI: 10.1007/S12603-009-0246-Z  0.327
2009 Gillioz AS, Villars H, Voisin T, Cortes F, Gillette-Guyonnet S, Andrieu S, Gardette V, Nourhashémi F, Ousset PJ, Jouanny P, Vellas B. Spared and impaired abilities in community-dwelling patients entering the severe stage of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 28: 427-32. PMID 19907179 DOI: 10.1159/000255635  0.668
2009 Coley N, Andrieu S, Delrieu J, Voisin T, Vellas B. Biomarkers in Alzheimer's disease: not yet surrogate endpoints. Annals of the New York Academy of Sciences. 1180: 119-24. PMID 19906266 DOI: 10.1111/J.1749-6632.2009.04947.X  0.711
2009 Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology. 73: 1359-66. PMID 19858457 DOI: 10.1212/Wnl.0B013E3181Bd80E9  0.419
2009 Delrieu J, Voisin T, Andrieu S, Belliard S, Belmin J, Blanchard F, Ceccaldi M, Dartigues JF, Defontaines B, Lehericy S, Mekies C, Moreaud O, Naccache L, Nourhashemi F, Ousset PJ, et al. Mild Alzheimer's disease: a "position paper". The Journal of Nutrition, Health & Aging. 13: 503-19. PMID 19536419 DOI: 10.1007/S12603-009-0101-2  0.398
2009 Salva A, Coll-Planas L, Bruce S, De Groot L, Andrieu S, Abellan G, Vellas B, Andrieu S, Bartorelli L, Berner YN, Bruce S, Corman B, Domingo A, Egger TP, et al. Nutritional assessment of residents in long-term care facilities (LTCFs): recommendations of the task force on nutrition and ageing of the IAGG European region and the IANA. The Journal of Nutrition, Health & Aging. 13: 475-83. PMID 19536415 DOI: 10.1007/S12603-009-0097-7  0.309
2009 Germain S, Adam S, Olivier C, Cash H, Ousset PJ, Andrieu S, Vellas B, Meulemans T, Reynish E, Salmon E. Does cognitive impairment influence burden in caregivers of patients with Alzheimer's disease? Journal of Alzheimer's Disease : Jad. 17: 105-14. PMID 19494435 DOI: 10.3233/JAD-2009-1016  0.31
2009 Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues JF, Touchon J, Vellas B. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 114-21. PMID 19328438 DOI: 10.1016/j.jalz.2009.01.008  0.401
2009 Rolland Y, Abellan van Kan G, Nourhashemi F, Andrieu S, Cantet C, Guyonnet-Gillette S, Vellas B. An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 16: 525-31. PMID 19276547 DOI: 10.3233/Jad-2009-0987  0.417
2009 Abellan van Kan G, Rolland Y, Nourhashémi F, Coley N, Andrieu S, Vellas B. Cardiovascular disease risk factors and progression of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 27: 240-6. PMID 19246908 DOI: 10.1159/000203365  0.672
2009 Andrieu S, Coley N, Aisen P, Carrillo MC, DeKosky S, Durga J, Fillit H, Frisoni GB, Froelich L, Gauthier S, Jones R, Jönsson L, Khachaturian Z, Morris JC, Orgogozo JM, et al. Methodological issues in primary prevention trials for neurodegenerative dementia. Journal of Alzheimer's Disease : Jad. 16: 235-70. PMID 19221415 DOI: 10.3233/Jad-2009-0971  0.722
2009 Gardette V, Cestac P, Cantet C, Reynish E, Lapeyre-Mestre M, Andrieu S, Vellas B. Comparaison européenne de la prescription de médicaments spécifiques antidémentiels : l’étude ICTUS Revue D'éPidéMiologie Et De Santé Publique. 57: S92. DOI: 10.1016/J.Respe.2009.07.003  0.664
2009 Gardette V, Cestac P, Andrieu S, Cantet C, Montastruc J, Nourhashemi F, Lapeyre-Mestre M, Vellas B. Profil d’utilisation des médicaments spécifiques antidémentiels et des psychotropes dans la maladie d’Alzheimer : l’étude Plasa Revue D'éPidéMiologie Et De Santé Publique. 57: S92. DOI: 10.1016/J.Respe.2009.07.002  0.659
2008 Vellas B, Coley N, Andrieu S. Disease modifying trials in Alzheimer's disease: perspectives for the future. Journal of Alzheimer's Disease : Jad. 15: 289-301. PMID 18953115  0.678
2008 Coley N, Andrieu S, Gardette V, Gillette-Guyonnet S, Sanz C, Vellas B, Grand A. Dementia prevention: methodological explanations for inconsistent results. Epidemiologic Reviews. 30: 35-66. PMID 18779228 DOI: 10.1093/Epirev/Mxn010  0.788
2008 Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B. GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data. Current Alzheimer Research. 5: 406-15. PMID 18690838  0.656
2008 Vellas B, Gillette-Guyonnet S, Andrieu S. Memory health clinics-a first step to prevention. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: S144-9. PMID 18631991 DOI: 10.1016/j.jalz.2007.11.001  0.363
2008 Cortes F, Nourhashémi F, Guérin O, Cantet C, Gillette-Guyonnet S, Andrieu S, Ousset PJ, Vellas B. Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 22-9. PMID 18631947 DOI: 10.1016/j.jalz.2007.10.018  0.311
2008 Coley N, Gardette V, Toulza O, Gillette-Guyonnet S, Cantet C, Nourhashemi F, Andrieu S, Grand A, Vellas B. Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study. Neuroepidemiology. 31: 69-79. PMID 18622142 DOI: 10.1159/000144087  0.768
2008 Soto ME, Andrieu S, Cantet C, Reynish E, Ousset PJ, Arbus C, Gillette-Guyonnet S, Nourhashémi F, Vellas B, Rainfray M, Richard-Harston S, Franco A, Couturier P, Pasquier F, Fenaert N, et al. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease Dementia and Geriatric Cognitive Disorders. 26: 109-116. PMID 18617740 DOI: 10.1159/000144073  0.328
2008 Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G. Endpoints for trials in Alzheimer's disease: a European task force consensus. The Lancet. Neurology. 7: 436-50. PMID 18420157 DOI: 10.1016/S1474-4422(08)70087-5  0.703
2008 Benoit PH, Andrieu S, Lechowski L, Gillette-Guyonnet S, Robert PH, Vellas B, Rainfray M, Emeriau JP, Franco A, Pasquier F, Frigard B, Michel B, Jeandel C, Touchon J, Brocker P, et al. Apathy and depression in alzheimer's disease are associated with functional deficit and psychotropic prescription International Journal of Geriatric Psychiatry. 23: 409-414. PMID 17918770 DOI: 10.1002/Gps.1895  0.393
2008 Nourhashémi F, Ousset PJ, Gillette-Guyonnet S, Cantet C, Andrieu S, Vellas B. A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer's disease patients (REAL.FR cohort). International Journal of Geriatric Psychiatry. 23: 460-5. PMID 17894422 DOI: 10.1002/gps.1904  0.338
2008 Soto ME, Nourhashemi F, Arbus C, Villars H, Balardy L, Andrieu S, Vellas B. Special acute care unit for older adults with Alzheimer's disease. International Journal of Geriatric Psychiatry. 23: 215-9. PMID 17645281 DOI: 10.1002/gps.1865  0.316
2008 Coley N, Andrieu S, Berrut G, Ousset P, Garnier P, Mathiex-Fortunet H, Vellas B. P4-015: One-leg balance and cognitive function: Data from the baseline assessment of the GuidAge study Alzheimer's & Dementia. 4: T671-T671. DOI: 10.1016/J.Jalz.2008.05.2079  0.631
2008 Ousset P, Andrieu S, Colley N, Mathiex-Fortunet H, Garnier P, Vellas B. P3-165: The guidage study-evolution of cognitive function assessments after one year of follow up: A 5-year double-blind, randomized trial of the efficacy of EGb 761 for the prevention of Alzheimer's disease in patients over 70 with a memory complaint Alzheimer's & Dementia. 4: T568-T568. DOI: 10.1016/j.jalz.2008.05.1731  0.324
2008 Gardette V, Andrieu S, Gillette-Guyonnet S, Nourhashémi F, Ousset PJ, Cantet C, Lapeyre-Mestre M, Montastruc J, Vellas B. P2-392: Predictive factors of discontinuation and switch of cholinesterase inhibitors in Alzheimer's disease Alzheimer's & Dementia. 4: T488-T488. DOI: 10.1016/J.Jalz.2008.05.1470  0.699
2008 Andrieu S, Barberger-Gateau P, Raffaitin C, Berr C, Tzourio C, Dartigues J-, Gin H, Fitten LJ, Ortiz F, Fairbanks L, Bartzokis G, Lu P, Ringman J, Heyn PC, Locher JL, ... ... Andrieu S, et al. 3rd IANA (International Academy on Nutrition and Aging) Meeting Nutrition, Exercise & Alzheimer and Clinical Trials on Sarcopenia August 1–2, 2008 Hyatt Regency Tamaya Resort 1300 Tuyuna Trail Santa Ana Pueblo, NM USA The Journal of Nutrition Health and Aging. 12: 419-426. DOI: 10.1007/Bf02982702  0.339
2007 Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jönsson L, Visser PJ, Ousset PJ, Vellas B, Jones RW, Burns A, Bullock R, et al. The ICTUS study: A prospective longitudinal observational study of 1,380 AD patients in Europe: Study design and baseline characteristics of the cohort Neuroepidemiology. 29: 29-38. PMID 17898521 DOI: 10.1159/000108915  0.444
2007 Berr C, Akbaraly TN, Nourashemi F, Andrieu S. [Epidemiology of dementia]. Presse Medicale (Paris, France : 1983). 36: 1431-41. PMID 17560760 DOI: 10.1016/J.Lpm.2007.04.022  0.392
2007 Andrieu S, Rive B, Guilhaume C, Kurz X, Scuvée-Moreau J, Grand A, Dresse A. New assessment of dependency in demented patients: impact on the quality of life in informal caregivers. Psychiatry and Clinical Neurosciences. 61: 234-42. PMID 17472590 DOI: 10.1111/J.1440-1819.2007.01660.X  0.344
2007 Helmer C, Andrieu S, Pérès K, Orgogozo JM, Vellas B, Dartigues JF. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease Dementia and Geriatric Cognitive Disorders. 23: 168-174. PMID 17215578 DOI: 10.1159/000098516  0.363
2007 Vellas B, Andrieu S, Sampaio C, Wilcock G. Disease-modifying trials in Alzheimer's disease: a European task force consensus. The Lancet. Neurology. 6: 56-62. PMID 17166802 DOI: 10.1016/S1474-4422(06)70677-9  0.436
2007 Vellas B, Andrieu S, Ousset PJ, Ouzid M, Mathiex-Fortunet H. The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint. Neurology. 67: S6-11. PMID 17101932 DOI: 10.1212/Wnl.67.9_Suppl_3.S6  0.475
2006 Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashemi F, Cantet C, Ousset PJ, Reynish E, Grandjean H, Vellas B. Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 61: 516-20. PMID 16720751  0.322
2006 Bennys K, Berr C, Delrieu J, Andrieu S, Vellas B, Touchon J, Gabelle A. P3-274: COMBINATION OF A FUNCTIONAL SYNAPTIC BIOMARKER (ERP) AND VERBAL FLUENCY TEST TO SELECT AMYLOID POSITIVE ELDERLY SUBJECTS IN CLINICAL TRIALS Alzheimer's & Dementia. 14: P1182-P1182. DOI: 10.1016/J.Jalz.2018.06.1634  0.311
2005 Vellas B, Gauthier S, Allain H, Andrieu S, Aquino JP, Berrut G, Berthel M, Blanchard F, Camus V, Dartigues JF, Dubois B, Forette F, Franco A, Gonthier R, Grand A, et al. [Consensus statement on severe dementia]. Presse Mã©Dicale (Paris, France : 1983). 34: 1545-55. PMID 16301969 DOI: 10.1016/S0755-4982(05)84221-6  0.333
2004 Lauque S, Arnaud-Battandier F, Gillette S, Plaze JM, Andrieu S, Cantet C, Vellas B. Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: A prospective randomized study Journal of the American Geriatrics Society. 52: 1702-1707. PMID 15450048 DOI: 10.1111/J.1532-5415.2004.52464.X  0.401
2004 Amouyal-Barkate K, Nourhashémi F, Andrieu S, Cantet C, Vellas B. [Patients with Alzheimer's disease living alone at home in the cohort of REAL.FR]. La Revue De Medecine Interne. 301s-306s. PMID 14710448 DOI: 10.1016/S0248-8663(03)80687-2  0.301
2002 Rivière S, Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Lauque S, Cantet C, Salva A, Frisoni G, Vellas B. Cognitive function and caregiver burden: predictive factors for eating behaviour disorders in Alzheimer's disease. International Journal of Geriatric Psychiatry. 17: 950-5. PMID 12325056 DOI: 10.1002/gps.724  0.32
2000 Nourhashémi F, Ousset PJ, Guyonnet S, Andrieu S, Rolland Y, Adoue D, Vellas B, Albarède JL. [Alzheimer's disease: from pathology to preventive methods?]. La Revue De Medecine Interne. 21: 524-32. PMID 10909152 DOI: 10.1016/S0248-8663(00)89228-0  0.312
2000 Nourhashemi F, Gillette-Guyonnet S, Andrieu S, Ghisolfi A, Ousset PJ, Grandjean H, Grand A, Pous J, Vellas B, Albarede JL. Alzheimer disease: protective factors. The American Journal of Clinical Nutrition. 71: 643S-649S. PMID 10681273 DOI: 10.1093/AJCN/71.2.643S  0.301
1998 Guyonnet S, Nourhashemi F, Andrieu S, Ousset P, Gray L, Fitten L, Vellas B, Albarede J. A prospective study of chances in the nutritional status of Alzheimer's patients Archives of Gerontology and Geriatrics. 26: 255-262. DOI: 10.1016/S0167-4943(98)80036-8  0.354
Show low-probability matches.